Reviewers: JIN Hao-sheng, CHEN Zhi-hong, SHI Ning, Literature Co-worker: LV Ling. Preliminary Efficacy and Safety of Perioperative Treatment of Camrelizumab Combined With Apatinib in Resectable Hepatocellular Carcinoma[J]. Journal of Evidence-Based Medicine, 2021, 21(6): 337-340. DOI: 10.12019/j.issn.1671-5144.2021.06.005
|
Citation:
|
Reviewers: JIN Hao-sheng, CHEN Zhi-hong, SHI Ning, Literature Co-worker: LV Ling. Preliminary Efficacy and Safety of Perioperative Treatment of Camrelizumab Combined With Apatinib in Resectable Hepatocellular Carcinoma[J]. Journal of Evidence-Based Medicine, 2021, 21(6): 337-340. DOI: 10.12019/j.issn.1671-5144.2021.06.005
|
Reviewers: JIN Hao-sheng, CHEN Zhi-hong, SHI Ning, Literature Co-worker: LV Ling. Preliminary Efficacy and Safety of Perioperative Treatment of Camrelizumab Combined With Apatinib in Resectable Hepatocellular Carcinoma[J]. Journal of Evidence-Based Medicine, 2021, 21(6): 337-340. DOI: 10.12019/j.issn.1671-5144.2021.06.005
|
Citation:
|
Reviewers: JIN Hao-sheng, CHEN Zhi-hong, SHI Ning, Literature Co-worker: LV Ling. Preliminary Efficacy and Safety of Perioperative Treatment of Camrelizumab Combined With Apatinib in Resectable Hepatocellular Carcinoma[J]. Journal of Evidence-Based Medicine, 2021, 21(6): 337-340. DOI: 10.12019/j.issn.1671-5144.2021.06.005
|
DownLoad: